Mutations in TP53 and DNA damage repair genes have a negative impact on the response to first-line systemic therapy in men with prostate cancer

被引:0
作者
Nientiedt, C. [1 ,2 ]
Wuenschel, A. -K [3 ]
Kaczorowski, A. [3 ]
Endris, V [4 ]
Zschaebitz, S. [1 ]
Jaeger, D. [1 ]
Hohenfellner, M. [5 ]
Stenzinger, A.
Duensing, S. [3 ]
机构
[1] NCT Natl Ctr Tumorerkrankungen Heidelberg, Med Onkol, Heidelberg, Germany
[2] Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany
[3] Urol Clin, Mol Uroonkol, Heidelberg, Germany
[4] Pathol Inst, Allgemeine Pathol, Heidelberg, Germany
[5] Urol Clin, Heidelberg, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
V836
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
[1]   Mutations in TP53 or DNA damage repair genes define poor prognostic subgroups in primary prostate cancer [J].
Nientiedt, Cathleen ;
Budczies, Jan ;
Endris, Volker ;
Kirchner, Martina ;
Schwab, Constantin ;
Jurcic, Christina ;
Behnisch, Rouven ;
Hoveida, Shirin ;
Lantwin, Philippa ;
Kaczorowski, Adam ;
Geisler, Christine ;
Dieffenbacher, Svenja ;
Falkenbach, Fabian ;
Franke, Desiree ;
Goertz, Magdalena ;
Heller, Martina ;
Himmelsbach, Ruth ;
Pecqueux, Carine ;
Rath, Mathias ;
Reimold, Philipp ;
Schuetz, Viktoria ;
Simunovic, Iva ;
Walter, Elena ;
Hofer, Luisa ;
Gasch, Claudia ;
Schoenberg, Gita ;
Pursche, Lars ;
Hatiboglu, Gencay ;
Nyarangi-Dix, Joanne ;
Sueltmann, Holger ;
Zschaebitz, Stefanie ;
Koerber, Stefan A. ;
Jaeger, Dirk ;
Debus, Jurgen ;
Duensing, Anette ;
Schirmacher, Peter ;
Hohenfellner, Markus ;
Stenzinger, Albrecht ;
Duensing, Stefan .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (01) :8.e11-8.e18
[2]   Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients [J].
Damien Vasseur ;
Ahmadreza Arbab ;
Fabiola Giudici ;
Christophe Marzac ;
Stefan Michiels ;
Marco Tagliamento ;
Arnaud Bayle ;
Cristina Smolenschi ;
Madona Sakkal ;
Mihaela Aldea ;
Hela Sassi ;
Filippo Gustavo Dall’Olio ;
Noémie Pata-Merci ;
Sophie Cotteret ;
Alice Fiévet ;
Nathalie Auger ;
Luc Friboulet ;
Francesco Facchinetti ;
Arthur Géraud ;
Santiago Ponce ;
Antoine Hollebecque ;
Benjamin Besse ;
Jean Baptiste Micol ;
Antoine Italiano ;
Ludovic Lacroix ;
Etienne Rouleau .
npj Precision Oncology, 8
[3]   Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients [J].
Vasseur, Damien ;
Arbab, Ahmadreza ;
Giudici, Fabiola ;
Marzac, Christophe ;
Michiels, Stefan ;
Tagliamento, Marco ;
Bayle, Arnaud ;
Smolenschi, Cristina ;
Sakkal, Madona ;
Aldea, Mihaela ;
Sassi, Hela ;
Dall'Olio, Filippo Gustavo ;
Pata-Merci, Noemie ;
Cotteret, Sophie ;
Fievet, Alice ;
Auger, Nathalie ;
Friboulet, Luc ;
Facchinetti, Francesco ;
Geraud, Arthur ;
Ponce, Santiago ;
Hollebecque, Antoine ;
Besse, Benjamin ;
Micol, Jean Baptiste ;
Italiano, Antoine ;
Lacroix, Ludovic ;
Rouleau, Etienne .
NPJ PRECISION ONCOLOGY, 2024, 8 (01)
[4]   Impact of TP53/KRAS mutations on overall survival of metastatic non-small cell lung cancer patients (pts) treated with systemic first-line therapy [J].
Novella, S. Rubio ;
Cobo, A. ;
Montes, A. ;
Lopez, J. Soler ;
Rondan, M. Arnal ;
Palanca, S. Noguera ;
Tena, I. ;
Miguel, J. ;
Navarro, B. ;
Domingo, I. ;
Esteban, S. Cases ;
Diaz, M. ;
Andrade, P. ;
Rosello, E. ;
Santander, J. R. Lazaro ;
Estelles, D. Lorente ;
Hernandez, A. Sanchez .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) :S80-S81
[5]   Functional TP53 mutations have no impact on response to cytotoxic agents in metastatic colon cancer [J].
Netter, Jeanne ;
Lehmann-Che, Jacqueline ;
Lambert, Jerome ;
Tallet, Anne ;
Lourenco, Nelson ;
Soliman, Hany ;
Bertheau, Philippe ;
Pariente, Benjamin ;
Chirica, Mircea ;
Pocard, Marc ;
Allez, Matthieu ;
De The, Hugues ;
Gornet, Jean-Marc .
BULLETIN DU CANCER, 2015, 102 (02) :117-125
[6]   Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling [J].
Macedo-Silva, Catarina ;
Miranda-Goncalves, Vera ;
Tavares, Nuno Tiago ;
Barros-Silva, Daniela ;
Lencart, Joana ;
Lobo, Joao ;
Oliveira, Angelo ;
Correia, Margareta P. ;
Altucci, Lucia ;
Jeronimo, Carmen .
SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
[7]   Epigenetic regulation of TP53 is involved in prostate cancer radioresistance and DNA damage response signaling [J].
Catarina Macedo-Silva ;
Vera Miranda-Gonçalves ;
Nuno Tiago Tavares ;
Daniela Barros-Silva ;
Joana Lencart ;
João Lobo ;
Ângelo Oliveira ;
Margareta P. Correia ;
Lucia Altucci ;
Carmen Jerónimo .
Signal Transduction and Targeted Therapy, 8
[8]   First-line immunotherapy for lung cancer with MET exon 14 skipping and the relevance of TP53 mutations [J].
Blasi, Miriam ;
Kuon, Jonas ;
Lueders, Heike ;
Misch, Daniel ;
Kauffmann-Guerrero, Diego ;
Hilbrandt, Moritz ;
Kazdal, Daniel ;
Falkenstern-Ge, Roger-Fei ;
Hackanson, Bjoern ;
Dintner, Sebastian ;
Faehling, Martin ;
Kirchner, Martina ;
Volckmar, Anna -Lena ;
Kopp, Hans -Georg ;
Allgaeuer, Michael ;
Grohe, Christian ;
Tufman, Amanda ;
Reck, Martin ;
Frost, Nikolaj ;
Stenzinger, Albrecht ;
Thomas, Michael ;
Christopoulos, Petros .
EUROPEAN JOURNAL OF CANCER, 2024, 199
[9]   Inherited mutations of DNA damage repair genes in a racially diverse cohort of men with prostate cancer [J].
Kohaar, Indu ;
Zhang, Xijun ;
Chesnut, Gregory ;
Dalgard, Clifton ;
Wilkerson, Matthew D. ;
Petrovics, Gyorgy .
CANCER RESEARCH, 2023, 83 (11)
[10]   Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase Inhibitors [J].
Canale, Matteo ;
Petracci, Elisabetta ;
Delmonte, Angelo ;
Chiadini, Elisa ;
Dazzi, Claudio ;
Papi, Maximilian ;
Capelli, Laura ;
Casanova, Claudia ;
De Luigi, Nicoletta ;
Mariotti, Marita ;
Gamboni, Alessandro ;
Chiari, Rita ;
Bennati, Chiara ;
Calistri, Daniele ;
Ludovini, Vienna ;
Crino, Lucio ;
Amadori, Dino ;
Ulivi, Paola .
CLINICAL CANCER RESEARCH, 2017, 23 (09) :2195-2202